Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma
Kevin Bi, Meng Xiao He, Ziad Bakouny, Abhay Kanodia, Sara Napolitano, Jingyi Wu, Grace Grimaldi, David A. Braun, Michael S. Cuoco, Angie Mayorga, Laura DelloStritto, Gabrielle Bouchard, John A. Steinharter, Alok K. Tewari, Natalie I. Vokes, Erin Shannon, Maxine Sun, Jihye Park, Steven L. Chang, Bradley A. McGregor, Rizwan Haq, Thomas Denize, Sabina Signoretti, Jennifer L. Guerriero, Sébastien Vigneau, Orit Rozenblatt–Rosen, Asaf Rotem, Aviv Regev, Toni K. Choueiri, Eliezer M. Van Allen
Topics & Concepts
Immune checkpointImmune systemCancer researchImmunotherapyTumor microenvironmentDownregulation and upregulationCytotoxic T cellRenal cell carcinomaBiologyCancer immunotherapyReprogrammingCancerCancer cellEffectorT cellCellImmunologyMedicineOncologyGeneGeneticsBiochemistryIn vitroCancer Immunotherapy and BiomarkersRenal cell carcinoma treatmentFerroptosis and cancer prognosis